Streptoduocin

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Streptoduocin is an aminoglycoside antibiotic.

CURRY FJ, SCHLESS JM, STOREY PB, WIER JA (December 1956). “Ototoxicity from intermittent streptoduocin therapy of pulmonary tuberculosis; a study of one hundred five patients treated eight to ten months”. Diseases of the Chest. 30 (6): 628–32. PMID 13375456. |access-date= requires |url= (help)
HEYWORTH F, HELM WH (August 1960). “A comparison of the toxic and allergic reactions occurring with streptomycin and streptoduocin in the treatment of pulmonary tuberculosis”. Postgraduate Medical Journal. 36: 516–8. doi:10.1136/pgmj.36.418.516. PMC 2481660. PMID 14401661. Retrieved 2012-08-24.
SHUBIN H, HEIKEN CA, GLASKIN A, PENNES E, CHAKRAVARTY S, RUTBERG F (October 1955). “A study of the neurotoxicity of streptoduocin on tuberculous patients”. Diseases of the Chest. 28 (4): 447–50. doi:10.1378/chest.28.4.447. PMID 13261867. |access-date= requires |url= (help)
Francis, R.S.; Gupta, S.K. (1958). “The use of corticotrophin in rapid desensitization to PAS”. Tubercle. 39 (4): 236–239. doi:10.1016/S0041-3879(58)80074-4. ISSN 0041-3879.
SHUBIN H (January 1956). “The preference for streptoduocin in the treatment of tuberculosis of the aging”. Journal of the American Geriatrics Society. 4 (1): 65–9. PMID 13286067. |access-date= requires |url= (help)